Related references
Note: Only part of the references are listed.β-Arrestin-2 BRET Biosensors Detect Different β-Arrestin-2 Conformations in Interaction with GPCRs
Atsuro Oishi et al.
ACS SENSORS (2020)
Signalling, trafficking and glucoregulatory properties of glucagon-like peptide-1 receptor agonists exendin-4 and lixisenatide
Philip Pickford et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Pharmacological characterization of mono-, dual- and tri-peptidic agonists at GIP and GLP-1 receptors
Elita Yuliantie et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Disconnect between signalling potency and in vivo ef fi cacy of pharmacokinetically optimised biased glucagon-like peptide-1 receptor agonists
Maria Lucey et al.
MOLECULAR METABOLISM (2020)
Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist
Francis S. Willard et al.
JCI INSIGHT (2020)
Differential GLP-1R Binding and Activation by Peptide and Non-peptide Agonists
Xin Zhang et al.
MOLECULAR CELL (2020)
Spatiotemporal GLP-1 and GIP receptor signaling and trafficking/recycling dynamics induced by selected receptor mono- and dual-agonists
Aaron Novikoff et al.
MOLECULAR METABOLISM (2020)
Ligand-Specific Factors Influencing GLP-1 Receptor Post-Endocytic Trafficking and Degradation in Pancreatic Beta Cells
Zijian Fang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The Influence of Peptide Context on Signaling and Trafficking of Glucagon-like Peptide-1 Receptor Biased Agonists
Zijian Fang et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)
Novel fatty chain-modified GLP-1R G-protein biased agonist exerts prolonged anti-diabetic effects through targeting receptor binding sites (Publication with Expression of Concern. See vol. 12, pg. 33348, 2022)
Maorong Wang et al.
RSC ADVANCES (2020)
A Biased View of μ-Opioid Receptors?
Alexandra E. Conibear et al.
MOLECULAR PHARMACOLOGY (2019)
Agonist-induced membrane nanodomain clustering drives GLP-1 receptor responses in pancreatic beta cells
Teresa Buenaventura et al.
PLOS BIOLOGY (2019)
Glucagon-like peptide 1 (GLP-1)
T. D. Mueller et al.
MOLECULAR METABOLISM (2019)
Switchable Solvatochromic Probes for Live-Cell Super-resolution Imaging of Plasma Membrane Organization
Dmytro Danylchuk et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Ureidopeptide GLP-1 analogues with prolonged activity in vivo via signal bias and altered receptor trafficking
Juliette Fremaux et al.
CHEMICAL SCIENCE (2019)
Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1
Daniel J. Drucker
CELL METABOLISM (2018)
IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
N. H. Cho et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2018)
Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes A Systematic Review and Meta-analysis
Sean L. Zheng et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Mini G protein probes for active G protein-coupled receptors (GPCRs) in live cells
Qingwen Wan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Is the Quest for Signaling Bias Worth the Effort?
Terry Kenakin
MOLECULAR PHARMACOLOGY (2018)
Targeting GLP-1 receptor trafficking to improve agonist efficacy
Ben Jones et al.
NATURE COMMUNICATIONS (2018)
Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis
M. Angelyn Bethel et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Glucagon-like peptide-1 receptor internalisation controls spatiotemporal signalling mediated by biased agonists
Madeleine M. Fletcher et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Phase-plate cryo-EM structure of a biased agonist-bound human GLP-1 receptor-Gs complex
Yi-Lynn Liang et al.
NATURE (2018)
Therapeutic Targeting of Endosomal G-Protein-Coupled Receptors
Alex R. B. Thomsen et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial
Juan Pablo Frias et al.
LANCET (2018)
A Targeted RNAi Screen Identifies Endocytic Trafficking Factors That Control GLP-1 Receptor Signaling in Pancreatic beta-Cells
Teresa Buenaventura et al.
DIABETES (2018)
DeconvolutionLab2: An open-source software for deconvolution microscopy
Daniel Sage et al.
METHODS (2017)
Functional selectivity of GPCR-directed drug action through location bias
Roshanak Irannejad et al.
NATURE CHEMICAL BIOLOGY (2017)
A BaSiC tool for background and shading correction of optical microscopy images
Tingying Peng et al.
NATURE COMMUNICATIONS (2017)
Internalized TSH receptors en route to the TGN induce local Gs-protein signaling and gene transcription
Amod Godbole et al.
NATURE COMMUNICATIONS (2017)
Gαs regulates Glucagon-Like Peptide 1 Receptor-mediated cyclic AMP generation at Rab5 endosomal compartment
Shravan Babu Glrada et al.
MOLECULAR METABOLISM (2017)
Systematic errors in detecting biased agonism: Analysis of current methods and development of a new model-free approach
H. Ongun Onaran et al.
SCIENTIFIC REPORTS (2017)
NanoLuc Complementation Reporter Optimized for Accurate Measurement of Protein Interactions in Cells
Andrew S. Dixon et al.
ACS CHEMICAL BIOLOGY (2016)
A Pluridimensional View of Biased Agonism
Claudio M. Costa-Neto et al.
MOLECULAR PHARMACOLOGY (2016)
Autocrine selection of a GLP-1R G-protein biased agonist with potent antidiabetic effects
Hongkai Zhang et al.
NATURE COMMUNICATIONS (2015)
Functional Consequences of Glucagon-like Peptide-1 Receptor Cross-talk and Trafficking
Sarah Noerklit Roed et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Automated Method for the Rapid and Precise Estimation of Adherent Cell Culture Characteristics from Phase Contrast Microscopy Images
Nicolas Jaccard et al.
BIOTECHNOLOGY AND BIOENGINEERING (2014)
Real-time trafficking and signaling of the glucagon-like peptide-1 receptor
Sarah Noerklit Roed et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
Endosomal generation of cAMP in GPCR signaling
Jean-Pierre Vilardaga et al.
NATURE CHEMICAL BIOLOGY (2014)
The GIP Receptor Displays Higher Basal Activity than the GLP-1 Receptor but Does Not Recruit GRK2 or Arrestin3 Effectively
Suleiman Al-Sabah et al.
PLOS ONE (2014)
Quantification of Ligand Bias for Clinically Relevant β2-Adrenergic Receptor Ligands: Implications for Drug Taxonomy
Emma T. van der Westhuizen et al.
MOLECULAR PHARMACOLOGY (2014)
Glucagon-like peptide-1 receptor-mediated endosomal cAMP generation promotes glucose-stimulated insulin secretion in pancreatic β-cells
Ramya S. Kuna et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2013)
Dynamic conformational transitions of the EGF receptor in living mammalian cells determined by FRET and fluorescence lifetime imaging microscopy
Iwona Ziomkiewicz et al.
CYTOMETRY PART A (2013)
Conformational biosensors reveal GPCR signalling from endosomes
Roshanak Irannejad et al.
NATURE (2013)
A Simple Method for Quantifying Functional Selectivity and Agonist Bias
Terry Kenakin et al.
ACS CHEMICAL NEUROSCIENCE (2012)
The effect of ligand efficacy on the formation and stability of a GPCR-G protein complex
Xiao Jie Yao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Oxyntomodulin differentially affects glucagon-like peptide-1 receptor β-arrestin recruitment and signaling through Gαs
Rasmus Jorgensen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Type 2 diabetes: principles of pathogenesis and therapy
M Stumvoll et al.
LANCET (2005)
Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion
HE Hohmeier et al.
DIABETES (2000)
Share Paper
